Metapneumonia Virus B RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Metapneumonia Virus B RNA Detection Qualitative Test for the detection of Metapneumonia Virus B (MPV-B) RNA in respiratory samples. This test is essential for diagnosing MPV-B infections and guiding appropriate treatment and control measures.
Test Details
The Metapneumonia Virus B RNA Detection Qualitative Test is a diagnostic test used to detect the presence of MPV-B RNA in a patient’s respiratory sample. MPV-B is a respiratory virus that can cause respiratory tract infections, especially in young animals.
The test utilizes a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the viral RNA. The respiratory sample, which can be collected through bronchial swabs, bronchial lavage, sputum, nasopharyngeal aspirates and swabs, or lung tissues, is processed to extract the viral RNA. The RNA is then reverse transcribed into complementary DNA (cDNA), which serves as a template for the PCR amplification.
During the PCR amplification, specific primers are used to target and amplify a region of the MPV-B RNA genome. If the MPV-B RNA is present in the sample, the primers will bind to the viral RNA and initiate the amplification process. The amplified DNA fragments are then detected using various methods, such as fluorescent probes or gel electrophoresis.
A positive result indicates the presence of MPV-B RNA in the patient’s respiratory sample, suggesting an active infection. A negative result suggests the absence of MPV-B RNA, indicating that the patient is likely not infected with MPV-B.
Test Cost and Components
The cost of the Metapneumonia Virus B RNA Detection Qualitative Test is AED 1450.0. The test components include bronchial swab, bronchial lavage, sputum, nasopharyngeal aspirates and swabs in viral transport medium, or lung tissues.
Symptoms and Diagnosis
MPV-B infections can cause respiratory tract infections, particularly in young animals. Common symptoms include cough, sneezing, nasal discharge, and difficulty breathing. Diagnosis of MPV-B infections is done through the Metapneumonia Virus B RNA Detection Qualitative Test, which detects the presence of MPV-B RNA in respiratory samples.
Referring and Report Delivery
To refer a patient for the Metapneumonia Virus B RNA Detection Qualitative Test, please consult a physician. The test is conducted in our Genetics Test Department.
The report delivery time for this test is as follows:
- Email: 4th working day (within 48 hours)
- Phone: 36 hours
Pre Test Information
Prior to the test, patients are required to sign a consent document and bring any clinical history related to Metapneumonia Virus B (RNA Detection) Qualitative Test.
Conclusion
The Metapneumonia Virus B RNA Detection Qualitative Test is an essential tool for diagnosing MPV-B infections and guiding appropriate treatment and control measures. It is commonly used in veterinary medicine to identify and manage respiratory diseases in animals, especially in livestock such as pigs and cattle.
Test Name | Metapneumonia Virus B RNA Detection Qualitative Test |
---|---|
Components | |
Price | 1450.0 AED |
Sample Condition | Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC. |
Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMetapneumonia Virus B (RNA Detection) QualitativeTest |
Test Details |
The Metapneumonia Virus B (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of Metapneumonia Virus B (MPV-B) RNA in a patient’s respiratory sample. MPV-B is a type of respiratory virus that can cause respiratory tract infections, particularly in young animals. The test utilizes a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the viral RNA. The respiratory sample, usually collected through nasal swabs or bronchoalveolar lavage, is processed to extract the viral RNA. The RNA is then reverse transcribed into complementary DNA (cDNA), which serves as a template for the PCR amplification. During the PCR amplification, specific primers are used to target and amplify a region of the MPV-B RNA genome. If the MPV-B RNA is present in the sample, the primers will bind to the viral RNA and initiate the amplification process. The amplified DNA fragments are then detected using various methods, such as fluorescent probes or gel electrophoresis. A positive result indicates the presence of MPV-B RNA in the patient’s respiratory sample, suggesting an active infection. A negative result suggests the absence of MPV-B RNA, indicating that the patient is likely not infected with MPV-B. The Metapneumonia Virus B (RNA Detection) Qualitative Test is an important tool for diagnosing MPV-B infections and guiding appropriate treatment and control measures. It is commonly used in veterinary medicine to identify and manage respiratory diseases in animals, particularly in livestock such as pigs and cattle. |